In previous work, we developed and validated an absolute risk prediction model for breast cancer incidence in US Black women [2], among whom there is a higher proportion of ER-negative vs. ER-positive tumors than in US women from other racial groups. The gene discussed is ESR1; the disease is breast cancer.